Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/34176
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKladieva, T. A.-
dc.contributor.authorPokrovskaya, T. G.-
dc.contributor.authorBelousova, Yu. V.-
dc.date.accessioned2020-07-24T11:55:48Z-
dc.date.available2020-07-24T11:55:48Z-
dc.date.issued2019-
dc.identifier.citationKladieva, T.A. Pharmacological correction of endothelial dysfunction using ademethionin and taurine / T.A. Kladieva, T.G. Pokrovskaya, Yu.V. Belousova // Research Results in Pharmacology. - 2019. - Vol. 5 (2). - P. 13-21. - Doi: 10.3897/rrpharmacology.5.32730.ru
dc.identifier.otherDoi: 10.3897/rrpharmacology.5.32730-
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/34176-
dc.description.abstractEndothelial dysfunction was simulated in male rats using the e-NOS inhibitor L-NAME (25 mg/kg/day intraperitoneally, for 7 days). Simulation of ADMA-like preeclampsia was performed by intraperitoneal injection of L-NAME to females in the same doses for 7 days (14-20th days of pregnancy). These pathologies were corrected by administering ademethionine in dose 150 mg/kg and taurine at a dose of 260 mg/kg, as well as their combination at the same doses, intragastrically, through an atraumatic probe, once a dayru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subjectendothelial dysfunctionru
dc.subjectpreeclampsiaru
dc.subjectpharmacological correctionru
dc.subjectademethionineru
dc.subjecttaurineru
dc.subjectnitrogen oxideru
dc.subjecthomocysteineru
dc.titlePharmacological correction of endothelial dysfunction using ademethionin and taurineru
dc.typeArticleru
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Kladieva_Pharmacological.pdf3.34 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.